Target intelligence / Profile preview

Sulfotransferase family 1D member 1 pseudogene 2 (SULT1D1P2)

Target
SULT1D1P2
Molecular classification
Other (Pseudogene)
01

Overview

SULT1D1P2 is a human pseudogene belonging to the sulfotransferase (SULT) family, specifically related to family 1D member 1. As a pseudogene, SULT1D1P2 does not encode a functional protein product and is not involved in enzymatic or receptor-based biological processes. There is no evidence supporting any role of SULT1D1P2 in normal physiology, disease, or drug targeting. Therefore, it is not considered a therapeutic target[5].

Other names
SULT1D1P2

Beyond the preview

Go deeper on Sulfotransferase family 1D member 1 pseudogene 2 (SULT1D1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulfotransferase family 1D member 1 pseudogene 2 (SULT1D1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call